DUBLIN--(BUSINESS WIRE)--May 11, 2015--
Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the UBS Global Healthcare Conference on Monday,
May 18, 2015, at 2:00 p.m. EDT (7:00 p.m. BST) from the Sheraton New
York Hotel. The presentation may be accessed under the Investors tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
developing innovative medicines for the treatment of central nervous
system (CNS) diseases. The company has a diversified commercial product
portfolio and a substantial clinical pipeline of product candidates for
chronic diseases that include schizophrenia, depression, addiction and
multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has
an R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more information, please visit Alkermes’ website
at www.alkermes.com.
Source: Alkermes plc
For Alkermes
Eva Stroynowski, +1 781 609 6823
Corporate
Communications